Aprutumab

Aprutumab Suppliers list
Company Name: Aladdin Scientific
Tel: +1-833-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:Aprutumab (anti-FGFR2)
CAS:1634620-63-5
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$119.9/100μg;$588.9/1mg;$1851.9/5mg;$2598.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 17754423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Aprutumab
CAS:1634620-63-5
Purity:95% Package:100ug;500ug;1mg
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 15926423062
Email: 422450190@qq.com
Products Intro: Product Name:Aprutumab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
Company Name: AntibodySystem  
Tel: 027-65279366 18162686757
Email: biolab-reagents@atagenix.com
Products Intro: Product Name:Research Grade Aprutumab(DHD47902)
CAS:1634620-63-5
Purity:PAGE:>95% Package:100ug;1mg
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 13720134139
Email: orders@jknbiochem.com
Products Intro: Product Name:Aprutumab
CAS:1634620-63-5
Purity:95% Package:100ug:500ug:1mg
Aprutumab Basic information
Product Name:Aprutumab
Synonyms:Aprutumab;Research Grade Aprutumab(DHD47902);Aprutumab (anti-FGFR2)
CAS:1634620-63-5
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Aprutumab Structure
Aprutumab Chemical Properties
storage temp. Store at -20°C
Safety Information
MSDS Information
Aprutumab Usage And Synthesis
UsesAprutumabis a fully human FGFR2 monoclonal antibody, which binds to the FGFR2 isoforms FGFR2-IIIb and FGFR2-IIIc. Aprutumab has the potential for solid tumors research.
Mechanism of actionType-2 fibroblast growth factor receptor antagonists
Aprutumab Preparation Products And Raw materials
Tag:Aprutumab(1634620-63-5) Related Product Information
Panitumumab Trastuzumab Abciximab Nimotuzumab Matuzumab Pertuzumab Batoclimab Nipocalimab Rozanolixizumab OMALIZUMAB